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The combined effects of high-energy shock waves and cytostatic drugs or
cytokines on human bladder cancer cells
K. Worle, P. Steinbach & F. Hofstiidter
Universitdt Regensburg, Institutfur Pathologie, D-93042 Regensburg, Germany.
Summary The effects of shock waves generated by an experimental Siemens lithotripter in combination with
cytostatic drugs or cytokines on several bladder cancer cell lines were examined in vitro. Proliferation after
treatment was determined with the 3-4,5-dimethylthiazol-2,5 diphenyl tetrazolium bromide assay. Dose
enhancement ratios were calculated for each drug and each shock wave application mode in order to
characterise the sensitising effect of shock wave pretreatment. The influence of the time between shock wave
and drug treatment as well as the effects of different sequences of shock wave and drug treatment or
concomitant treatment were assessed for selected combinations of cell lines and drugs. It was found that shock
wave treatment could render certain cell lines more susceptible to subsequent cis-platinum, mitomycin C or
actinomycin D incubation. Cell lines sensitive to tumour necrosis factor a or interferon a were further
sensitised to these cytokines by shock wave pretreatment. The enhanced sensitivity to cis-platinum and
actinomycin D decreased rapidly during the first hours after shock wave treatment. The antiproliferative effect
was most pronounced after concomitant shock wave and drug treatment. The sensitisation to interferon a
diminishes more slowly after shock wave exposure. From the results presented in this study it is concluded that
transient shock wave-induced permeabilisation of cell membrane not only enhances drug efficiency, but also
causes damage to cell organelles and alterations in cellular metabolism
For more than a decade, high-energy shock waves (HESW)
have been routinely used to disintegrate urinary calculi
(Simon et al., 1989). Nowadays, even biliary and salivary
stones can be fragmented by extracorporeal shock wave
lithotripsy (Sackman & Paumgartner, 1992; Iro et al., 1992).
Although the patient's stress is reduced as compared with
open surgery, lithotripsy causes well-described side effects, in
particular damage to the vascular system (haemorrhages,
capillary thrombi, haematuresis), release of cytoplasmic
enzymes and cellular alterations in the tissue adjacent to the
treated loci (Lingeman et al., 1988; Brummer et al., 1990).
The possibility of exposing a spatially limited region of the
body to a potentially destructive form of mechanical energy
led to the idea of employing HESW in tumour therapy
(Russo et al., 1985). Appropriate in vitro and in vivo studies
showed that shock waves cause only temporary growth delay.
Nevertheless, considerable morphological changes at the cel-
lular level could be observed, including effects on plasma
membrane, mitochondria, cytoplasm and nucleus (Russo et
al., 1987; Randazzo et al., 1988; Brauner et al., 1989; Kohri
et al., 1990; Yu et al., 1991; Steinbach et al., 1992). These
damaging effects may be utilised in sensitising tumour cells to
other cytotoxic agents. First experiments with combinations
of HESW and drug treatment showed that certain treatment
modalities cause additive or synergistic reduction in prolifera-
tion (Wilmer et al., 1989; Berens et al., 1989; Holmes et al.,
1990; Lee et al., 1990; Chung et al., 1991; Hoshi et al., 1992;
Warlters et al., 1992; Gambihler & Delius, 1992). In vivo,
complete regression of experimental tumours can be observed
by combining HESW with cytokine therapy (Oosterhof et al.,
1991). Although various theories ofhow shock waves interact
with cellular structures and interfere with drug action have
been discussed, the underlying mechanisms remain to be
elucidated in detail.
In this study we examined the combination of shock waves
and drug treatment on a series of human bladder cancer cell
lines representing different phenotypes of malignancies of the
same organ. cis-Platinum, mitomycin C and actinomycin D
as drugs commonly employed in cancer chemotherapy were
selected, as well as tumour necrosis factor a and interferon a,
which are cytokines known to exert cytotoxic effects on
certain tumour cell lines. These drugs exert essentially
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different effects on tumour cells. Various treatment modalities
were examined. The observed response patterns are discussed
with regard to the modes of action of the substantially
different drugs and in view of possible interaction mech-
anisms with shock waves.
Materials and methods
Cell culture
Three human transitional carcinoma cell lines were evalu-
ated. RT4 (Rigby & Franks, 1970) and J82 (O'Toole et al.,
1978) represent the phenotype of a differentiated GI papil-
lary carcinoma and a highly malignant G3 carcinoma of the
bladder respectively, whereas MGH-Ul (Lin et al., 1985) is a
poorly differentiated subline of T24 originating from a G3
malignancy of the bladder. All cell lines were serially pas-
saged as monolayer cultures in RPMI-1640 medium (Bio-
chrom, Berlin, Germany) containing 10% fetal calf serum
(FCS), 1% penicillin/streptomycin, 1% sodium pyruvate and
1% L-glutamine (all from Gibco, Eggenstein, Germany). The
cell culure flasks (Greiner, Frickenhausen, Germany) were
incubated in a humidified atmosphere containing 5% carbon
dioxide at 37°C. Cells grown to subconfluence were washed
with phosphate-buffered saline (PBS; Biochrom) and har-
vested by a 3 min treatment with 0.25% trypsin/0.02%
EDTA (Gibco) in PBS. After centrifugation the cells were
resuspended in RPMI/FCS for further processing.
Pellet system
Aliquots of 3 ml of cell suspension adjusted to 3-5 x 106
cells ml-l were placed in small polyethylene vials (70 x 9 mm;
Nunc, Wiesbaden, Germany). Hydrophone measurements
showed that peak pressure and pressure profile were only
slightly altered inside the tubes (data not shown). Cells were
pelleted by centrifugation at 600g in order to minimise the
motion of the cells during shock wave treatment. Thus, we
could exclude intercellular collisions as a damaging effect that
probably plays a minor role in the in vivo situation. After
HESW treatment cells loosened from the pellet were removed
and the remainder were resuspended with medium. The cells
were seeded at equal concentrations into 96-well microtitre
plates (Greiner). Drugs were added after cell attachment
(unless otherwise stated after 4-5 h) at serial dilutions cover-
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ing a wide range of concentrations. A period of 4-5 h
proved to be sufficient for cell adherence even for shock
wave-treated cells. However, to assess the effect of drug
treatment immediately after HESW exposure, cells were
seeded directly into medium containing drug at the desired
concentrations (approximately 5 min after the end of HESW
treatment). Drug remained in the culture medium for a 72 h
incubation period. Sham-treated controls were processed
similarly.
Suspension system
In order to provide the possibility of unimpeded drug
delivery during HESW treatment, cell suspensions of the
above-stated density and volume were placed in polyethylene
vials. Drugs were added at concentrations that scarcely
reduced cell viability and removed 12 min later. Drug treat-
ment was performed either prior to, simultaneously with or
after HESW treatment. The time required for adding the
drug, applying the shock wave treatment and handling the
samples for drug removal (centrifugation, sucking drug,
resuspension) was 12 min. For sequential treatments the
handling time between the two treatment modalities was at
most 5 min. The cells were plated at equal concentrations
into 96-well microtitre plates and placed in an incubator for
72 h. Controls receiving no treatment or one of the two
treatment modalities (drug, shock waves) exclusively were
processed accordingly.
Shock wave exposure
As a shock wave device we employed an experimental
apparatus built by Siemens (Erlangen, Germany). The
electromagnetic shock wave generator is identical to the one
used in the commercially available Lithostar Plus system. The
experimental set-up is described in detail by Steinbach et al.
(1992) and Folberth et al. (1992) and is shown in Figure 1.
Briefly, exposure vials containing tumour cells were posi-
tioned in the focus of the shock wave device. Control cells
were left outside the focal region but within the temperature-
controlled water bath. For brevity, the treatment modalities
are designated as follows: 0, controls receiving no shock wave
treatment; 1, delivery of 200 pulses with an energy density of
0.33 mJ MMf2; 2, 1,000 pulses, 0.33 mJ mm-2; 3, 200 pulses,
M-2 0.6mJmm
Drugs
Three cytostatic drugs used for conventional chemotherapy
were chosen: cis-diammine-dichloro-platinum(II) (CDDP),
mitomycin C (MMC) and actinomycin D (AMD) (all from
Sigma Chemie, Deisenhofen, Germany). In addition, two
cytokines, tumour necrosis factor a (TNF-a, human recom-
binant; kindly provided by Knoll, Ludwigshafen, Germany)
and interferon a (IFN-o, human recombinant; Essex Pharma,
Munich, Germany), were included in this study. CDDP,
MMC and AMD were initially dissolved in 0.9% saline
(3 mM), PBS (3 mM) and ethanol (0.8 mM) respectively and
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Figure 1 Schematic diagram of experimental set-up for shock wave treatment of tumour cells. The curves on the left illustrate the
development of an ultrasonic shock front due to non-linear propagation in water. The insert on the upper part shows the spatial
distribution of the energy density in the direction perpendicular to the incident shock wave.60 K. WORLE et al.
further diluted with full RPMI medium in order to obtain
stock solutions in the 5-50 LM range, which were divided
into aliquots and stored at - 20°C. TNF-a was diluted with
RPMI/FCS to a concentration of 104 unitsml-l and stored
as aliquots at - 20°C. IFN-a was dissolved in RPMI/FCS
immediately before use.
Flow cytometry
Cells were stained with propidium iodide (PI) and fluorescein
diacetate (FDA) (both from Sigma Chemie) directly after
shock wave exposure (Flanigan et al., 1986). Fluorescence
intensity was detected with a FACScan flow cytometer
(Becton Dickinson, Heidelberg, Germany). PI is a polar com-
ponent that penetrates damaged, i.e. permeabilised, cell mem-
branes and intercalates into double-stranded DNA and
RNA. The non-polar, non-fluorescent FDA is deacetylated
by intracellular esterases of living cells to yield the fluorescent
and highly polar fluorescein. Only cells able to metabolise
FDA were evaluated. In cells lacking membrane integrity,
fluorescein slowly diffuses out of the cell. Thus, the fraction
of cells failing to exclude PI and the mean fluorescence
intensity of intracellular fluorescein served as an estimate of
plasma membrane damage.
Proliferation assay
Proliferation of cells after HESW and/or drug treatment was
tested after a further 72 h incubation period in the microtitre
plates with the 3-4,5 dimethylthiazol-2,5 diphenyl tetrazolium
bromide (MTT) assay (Mosmann, 1983). Briefly, 10pl of
MTT solution (Sigma Chemie; 5 mgml-' in PBS) was added
to each well containing 100 gld of medium. After 4 h incuba-
tion, 100 tlI of sodium dodecyl sulphate solution (Sigma
Chemie; 20% in water) was added to each well. The plates
were left overnight at 37°C, and absorption at 540 nm was
measured using an Emax microplate reader (Molecular
Devices, Menlo Park, CA, USA). The density of inoculated
cells was adjusted so that cells did not grow to confluence
during the incubation period. This ensured a linear relation-
ship between optical density and cell number over a wide
range (data not shown). In preliminary experiments we
confirmed that neither drug nor shock wave effects interfered
with the MTT reaction at the time the assay was to be
performed (results not shown). As a quality control measure,
we required that the untreated control wells of the plate had
an optical density of at least 1.0 units, with a coefficient of
variation (standard deviation divided by mean) of less than
0.1.
Data analysis and statistics
Each individual experiment was carried out at least in trip-
licate. For the proliferation assays in microtitre plates (MTT
test), at least eight individual wells were plated with cells
treated in an identical manner and their mean optical density
used for data analysis.
The dose-response curves resulting from the experiments
with the pellet system were evaluated for each shock wave
application mode in order to determine the drug concentra-
tions needed to inhibit cell proliferation by 20%, 50% and
80% (IC20, IC50, IC80) relative to cells without drug treat-
ment. The dose enhancement ratios (DERs) were calculated
as the ratio of the IC values without shock wave exposure
divided by the IC value resulting from the shock wave-
treated specimen. Only those DERs whose corresponding IC
values are significantly different (P<0.05) are displayed.
The effects of the different treatment modalities in the
suspension system were characterised as the relative prolifera-
tion of treated cells compared with untreated controls. The
results were checked with regard to possible synergistic
interactions under the assumption of the additivity model in
analogy with the method described by Welander et al. (1985).
The expected relative cell growth was calculated as the pro-
duct of the relative proliferation for each treatment
separately and compared with the observed cell growth after
combined treatment. If the difference between expected and
observed value is statistically signficant at P<0.05, the
results are considered to be synergistic. Higher P-values sug-
gest only additive effects.
Differences were tested for statistical significance with the
two-sided t-test. All primary data are presented as means
with standard deviations of the mean.
Results
With the pellet system we were able to study in detail pos-
sible sensitising effects of shock waves for subsequent drug
treatment. Figure 2 represents a typical dose-response pat-
tern from which IC20, IC50 and IC80 and subsequently DER
values were calculated. Tables I-V show the modulation of
the chemosensitivity for the three bladder cancer cell lines
and the different drugs under investigation. All cell lines
responded to incubation with the three cytostatic drugs
CDDP, MMC and AMD, though on slightly different scales.
RT4 proved to be most sensitive to IFN-a; J82 may be
regarded as semisensitive, whereas MGH-U1 was relatively
resistant. The only cell line whose proliferation could be
markedly decreased by TNF-a was RT4. Nevertheless, no
complete growth inhibition could be obtained within the
range of concentrations tested in this study (maximum
I0O Uml-').
The DERs of Tables I-V were calculated as described
above. The sensitivity to CDDP could be moderately
enhanced by HESW pretreatment in all cell lines. The suscep-
tibility to MMC showed no such uniform enhancement. We
observed only a small DER for RT4, a more pronounced
effect for J82, and higher DERs for MGH-U1. Only MGH-
Ul could be sensitised for AMD by HESW, resulting in the
highest DERs observed in our experiments. Although RT4
and J82 were similarly susceptible to AMD, they were not
sensitised to this drug by shock waves. In contrast, we found
considerable DERs of IFN-o for RT4 and J82, but not for
MGH-U1. In addition, HESW enhanced the inhibitory effect
of TNF-a on the proliferation of RT4 cells.
After shock wave exposure, regeneration processes start to
repair cellular damage (Holmes et al., 1992). For this reason,
we evaluated the effect of drug addition at various times after
HESW treatment for selected combinations of drugs and cell
lines. The resulting DERs are displayed in Figure 3. The
enhancement ratios gradually diminished during the period
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Figure 2 Dose-response curves for J82 and CDDP. (0) refer to
cells without HESW exposure; (0) refer to HESW-treated cells
(200 pulses, 0.6 mJ min-2). Cells without CDDP incubation
served as reference for proliferation (= 1.0).HESW EFFECTS ON BLADDER CANCER CELLS 61
Table I CDDP sensitivity ofcell lines pretreated with various shock wave application modes: 0,
control; 1, 200 pulses with 0.3 mJ mm-2; 2, 1,000 pulses with 0.3 mJ mm-2; 3, 200 pulses with
0.6 mJ mm-2. After seeding in 96-well plates and attachment the drug was added at a series of
dilutons; after a further 72 h incubation cell proliferation was evaluated by the MTT test and the
inhibitory concentrations were determined
CDDP RT4 J82 MGH-UJ
(n = 5) tLM a DER tLM a DER yM a DER
IC20
0 0.48 0.06 0.23 0.03 0.87 0.08
1 0.38 0.07 (1.3) 0.19 0.03 - 0.54 0.14 1.6
2 0.24 0.05 2.0 0.12 0.02 1.9 0.57 0.25 -
3 0.28 0.04 1.7 0.12 0.03 1.9 0.45 0.26 (1.9)
IC50
0 1.71 0.14 0.77 0.08 2.66 0.18
1 1.52 0.13 - 0.70 0.13 - 2.10 0.23 (1.3)
2 1.20 0.20 1.4 0.53 0.09 1.5 1.83 0.40 1.5
3 1.23 0.19 1.4 0.50 0.11 1.5 1.84 0.31 1.4
IC80
0 5.76 0.97 2.58 0.35 10.6 1.1
1 6.00 1.02 - 2.60 0.43 - 10.5 1.4 -
2 5.81 0.84 - 2.15 0.49 - 8.9 2.4 -
3 5.15 0.78 - 2.07 0.45 - 7.5 2.5 (1.4)
n.d. =not determined. Dose enhancement ratios were calculated from the inhibitory
concentrations. Figures indicate asignificant difference at P<0.01; figures inparentheses indicate a
significantdifference atP<0.05;-, nosignificantdifference betweenshockwave-treated andcontrol
cells.
Table II MMC sensitivity ofcell lines; see Table I for explanation
CDDP RT4 J82 MGH-UI
(n = 5) )AM a DER yM a DER JAM a DER
IC20
0 0.15 0.02 0.096 0.011 0.26 0.04
1 0.14 0.04 - 0.083 0.009 - 0.20 0.07 -
2 0.10 0.02 1.5 0.051 0.007 1.9 0.15 0.03 1.7
3 0.11 0.04 - 0.067 0.012 1.4 0.19 0.06 -
IC5
0 0.54 0.05 0.36 0.054 0.79 0.06
1 0.52 0.10 - 0.33 0.066 - 0.52 0.16 (1.5)
2 0.42 0.05 1.3 0.22 0.071 1.6 0.41 0.12 1.9
3 0.43 0.09 - 0.29 0.077 - 0.53 0.13 (1.5)
IC80
0 1.83 0.23 1.47 0.13 4.2 0.50
1 1.90 0.42 - 1.36 0.24 - 3.5 0.69 -
2 1.63 0.24 - 0.96 0.20 1.5 3.4 0.55 (1.2)
3 1.69 0.35 - 1.25 0.25 - 3.8 1.0 -
Table III AMD sensitivity ofcell lines; see Table I for explanation
CDDP RT4 J82 MGH-UJ
(n =5) JM a DER Am a DER JiM a DER
IC20
0 7.4 0.8 1.7 0.22 4.8 0.42
1 7.2 0.7 - 1.4 0.40 - 1.2 0.17 4.0
2 5.5 1.4 (1.3) 1.4 0.39 - 0.62 0.26 7.7
3 5.7 1.8 - 1.3 0.20 (1.3) 0.50 0.31 9.6
IC50
0 22.3 2.5 8.8 1.3 11.5 0.77
1 23.0 2.1 - 7.5 2.2 - 5.2 0.30 2.2
2 19.5 4.0 - 6.9 1.8 - 3.0 0.40 3.8
3 20.7 4.7 - 7.2 1.4 - 3.1 0.48 3.7
IC80
0 65.4 7.2 49 9.5 27.1 2.4
1 71.4 8.2 - 40 8.5 - 16.0 1.6 1.7
2 66.2 12.0 - 35 9.6 - 11.9 1.8 2.3
3 70.5 13.8 - 55 21.0 - 10.8 1.9 2.562 K. WORLE et al.
Table IV IFN-a sensitivity of cell lines; see Table I for explanation
IFN-a RT4 J82 MGH-U1
(n = 4) Uml' a DER Uml-' a DER Umi-' a DER
IC20
o 160 20 700 100 1.5 x 10 2.4x103
1 98 20 1.6 720 110 - 1.6x 104 3.2x10 -
2 59 8.5 2.7 370 95 1.9 2.1 x 104 4.6x 103 -
3 55 14 2.9 370 32 1.9 1.4x 104 2.5x 103 -
IC50
0 1,300 140 8,200 680 8.0 x 104 1.0 x 10
1 930 120 (1.4) 7,600 710 - 7.8 x 104 1.2 x 10 -
2 650 74 2.0 3,700 720 2.2 8.4 x 104 1.5 x 10 -
3 880 105 1.5 4,500 370 1.8 8.1 x 104 8.4 x 103 -
IC80
0 1.4 x 104 960 1.1 x 106 9.0 x 104 n.d.
1 1.2 x 10 1400 - 9.4 x 105 9.5 x 10 (1.2) n.d.
2 1.0x 104 980 1.4 7.9x 105 1.2x 105 1.4 n.d.
3 1.0 x 104 1200 1.4 5.8 x 105 7.2 x 10' 1.9 n.d.
Table V TNF-a sensitivity of RT4 cells; see T.able I for explanation
TNF-x RT4
(n = 3) Urmn-' a DER
IC20
0 1,050 180
1 770 110 -
2 420 110 (2.5)
3 390 80 (2.7)
IC50
0 4.9 x 103 570
1 4.4 x 103 550 -
2 2.4 x 103 780 (2.0)
3 2.7 x 103 490 (1.8)
IC80
0 n.d.
1 n.d.
2 n.d.
3 n.d.
5
0
o
c
0)
E
0)
C)
Co
0)
0)
cn
0
0
4
3
2
of 40 h tested in this study. The decline was very rapid for
J82 and CDDP and for MGH-Ul and AMD. The loss of
increased IFN-a sensitivity of RT4 cells extended over a
longer period of time.
To assess the effects of concomitant treatments and
treatments in direct sequence, the HESW exposure was per-
formed with the suspension system. In this way, adequate
drug delivery to the cells and short handling times could be
guaranteed. The modulation of cell proliferation by different
treatment regimens is depicted in Figure 4. Single treatments
of either drug or shock waves produced, if any, only slight
growth inhibition at the chosen concentrations and HESW
parameters. For all combinations of cell lines and drugs, the
inhibitory effect was smallest when drug incubation preceded
HESW exposure, and became most pronounced for simul-
taneous treatments. The growth reduction caused by con-
comitant CDDP and HESW treatment was diminished by
subsequent HESW exposure after drug removal (significant
for J82: P<0.05). Results that indicate synergistic interac-
tions of the two treatment modalities are marked in Figure 4.
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Figure 3 Dose enhancement ratio dependent on different times
of drug addition (A, J82 and CDDP; 0, MGH-U1 and AMD;
0, RT4 AND IFN) after HESW exposure; 0 h denotes seeding
of cells directly into drug-containing medium; other time points
refer to drug addition after cell attachment.
J82/CDDP RT4/CDDP MGH-U1/AMD
E Drug
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M HESW prior to drug
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Figure 4 Relative proliferation after single or combined treat-
ment regimens and a further 72 h incubation as determined by
the MTT test. Control cells receiving no treatment served as a
reference (= 1.0). Synergistic effects under assumption of the
additivity model are marked with asterisks. *P<0.05,
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The results of flow cytometric measurements are sum-
marised in Table VI. The extent of cell damage, characterised
as the percentage of PI-positive cells and the intensity of
fluorescein fluorescence, was not altered by a 12 min incuba-
tion with CDDP. Shock wave exposure, however, affected
these parameters. The portion of cells accumulating PI was
moderately higher for the suspension system than for the
pellet system and for RT4 cell as compared with J82 cells.
Cells exposed in suspension showed a slightly decreased
fluorescein fluorescence. Contemporaneous CDDP incuba-
tion produced a minor increase in PI-stained cells.
Discussion
Previous in vitro studies have demonstrated that HESW can
cause various types of cell damage. Apart from immediately
lethal effects such as fragmentation of cells, permeabilisation
of plasma membrane, swollen mitochondria with distorted
cristae, disturbed mitochondrial membrane potential, altered
vimentin structure, cytoplasmic cisternae and nuclear changes
have been described (Russo et al., 1987; Randazzo et al.,
1988; Brauner et al., 1989; Kohri et al., 1990; Yu et al., 1991;
Steinbach et al., 1992). Moreover, metabolic changes in
HESW-treated tumours have been reported (Smits et al.,
1991). However, first experiments with combinations of
HESW and cytostatic drugs did not yield uniform results.
For example, in experimental systems enhanced effects of
CDDP or adriamycin in combination with HESW were
reported while in others no such effects could be observed
(Randazzo et al., 1988; Wilmer et al., 1989; Berens et al.,
1989; Holmes et al., 1990; Lee et al., 1990; Chung et al.,
1991; Gambihler & Delius, 1992). Additional data are needed
to achieve a thorough understanding of the interactions of
HESW and tumour cells. In this study employing a series of
bladder cancer cell lines, the effects of certain drugs in com-
bination with HESW exposure seemed to be similar for all
cell lines; however, the effects of others were highly depen-
dent on the specific cell line under investigation.
The sensitivity to CDDP could be uniformly increased by
HESW pretreatment for all cell lines. This sensitising effect
diminished rapidly during the first hours after HESW
exposure. In addition, experiments with high CDDP concen-
trations over a short incubation time revealed that the com-
bined growth-inhibitory effect becomes most pronounced for
simultaneous treatments. HESW exposure prior to CDDP
incubation produced a modest growth inhibition, whereas
CDDP treatment before HESW exposure did not result in
reduced proliferation significantly different from those of
either treatment modality alone. This observation is in accor-
dance with the results of Lee et al. (1990) and strongly
supports the assumptions of Gambihler & Delius (1992) that
attribute enhanced CDDP toxicity in combination with
HESW to temporarily increased plasma membrane perme-
ability. CDDP is a relatively polar, i.e. hydrophilic, molecule
that normally crosses the lipid bilayer of the plasma mem-
brane at a slow rate, mainly by passive diffusion (Hecquet et
al., 1986). HESW exposure could transiently permeabilise the
cell membrane, thus reducing the diffusion barrier for CDDP
and increasing CDDP influx in analogy with results obtained
by ultrasQund exposure (Ellwart et al., 1987; Kober et al.,
1989; Fahnestock et al., 1989) or electropermeabilisation of
cells (Melvik et al., 1986). This interpretation seems
reasonable regarding the enhanced proliferation capacity fol-
lowing a second HESW administration after concomitant
CDDP/HESW treatment. As intracellular CDDP shows only
slow efflux rates (Troger et al., 1992), a second shock wave
permeabilisation of the cell membrane after removal of extra-
cellular drug could increase efflux of active CDDP before
being bound to intracellular target sites and consequently
increase the survival rate of the cells. Recently, analogous
observations were made for electropermeabilisation of cells
(Melvik et al., 1992). Flow cytometric measurements supply
an additional clue to membrane permeabilisation by HESW.
PI influx is clearly increased after HESW treatment, as well
as fluorescein efflux, though to a lesser extent. The RT4 cell
line showed higher PI uptake, reflecting its higher suscep-
tibility to concomitant and subsequent HESW/CDDP treat-
ments. As previously reported (Gambihler et al., 1992), there
is a fraction of fluorescein-positive cells that is also PI
positive but obviously proliferates, indicating that these cells
are able to recover from the membrane damage that leads to
PI uptake. Again, there is a remarkable similarity to electro-
permeabilisation, the effect of which is entirely reversible
(Melvik et al., 1986). However, this sublethal membrane
damage could lead to the introduction of a potentially lethal
dose of CDDP into the cell.
The fact that there remains an enhanced sensitivity to
CDDP even several hours after HESW treatment, as well as
the combined effects of HESW and the other drugs, may be
attributed to other shock wave-related effects. MMC exhibits
a more lipophilic character than CDDP and accumulates
more readily in cells (Wallner et al., 1987). MMC showed a
moderately higher efficiency similar for all cell lines after
HESW pretreatment. Concurrent HESW and high-dose
MMC treatment could not result in synergistic effects similar
to those of CDDP (data not shown). Therefore, we have to
assume that there occurs a cellular alteration that may be
similar to those observed in hyperthermic or radiation
enhancement of MMC action (Barlogie et al., 1980). Besides
changes in drug accumulation, increased drug activation,
inhibition of repair processes and improved accessibility of
DNA targets are discussed (Lokich & Byfield, 1991).
AMD, in contrast, is a highly lipophilic substance that
diffuses rapidly through the plasma membrane (Orlowski et
al., 1988). Sensitivity to AMD could be enhanced only in
MGH-U1, reaching the highest DER values observed in this
study. The DER of AMD decreases very rapidly during the
first hours after HESW exposure. High-dosage combination
treatments resulted in synergistic growth-inhibitory effects
similar to those reported for CDDP treatments. However,
even AMD pretreatment produced a synergistic effect, and a
Table VI Evaluation offlow cytometry measurements, percentage ofPI-stained cells and mean relative
intensity of fluorescein fluorescence for different treatments
J82 RT4
Fluorescein Fluorescein
PIpositive intensity PIpositive intensity
(%) a Ir/Iconr. a (%) a I'r./Icontr. a
Control 3.9 1.7 4.6 0.4
CDDP 4.3 2.2 1.03 0.06 4.6 1.2 1.13 0.06
HESW, pellet 10.8 6.0 0.96 0.08 18.4 7.5 1.0 0.04
HESW, suspension 14.8 5.3 0.89 0.03 26.0 4.2 0.85 0.10
HESW + CDDP 17.4 4.4 0.90 0.12 29.1 6.0 0.90 0.03
'CDDP', 12 min incubation with 15I4M CDDP in suspension; HESW, pellet/suspension, cell
pellet/suspension exposed to 200 shock wave pulses of 0.6 mJ min-2; HESW + CDDP, cell suspension
after simultaneous HESW and CDDP treatment.64 K. WORLE et al.
second HESW exposure after simultaneous AMD/HESW
treatment further enhanced growth inhibition, thus indicating
an additional damage to the cells. Electropermeabilisation
does not result in increased AMD sensitivity of cells (Orlow-
ski et al., 1988). As a consequence, membrane damage can be
excluded as the main component mediating the combined
action of HESW and AMD on MGH-Ul cells. Concerning
combined treatments with hyperthermia or radiation and
AMD, a reduction in the ability to absorb sublethal damage
is discussed by Ziegler et al. (1987) and Komatsu et al.
(1988). This seems reasonable since AMD binds preferen-
tially to nucleolar chromatin and impairs ribosomal RNA
synthesis (Yu & Bender, 1990). However, a reduced capacity
to repair damage caused by HESW should apply to all cell
lines, in accordance with results obtained for combination
therapies involving radiation or heat. On the other hand,
AMD shows a range of highly specific cellular reactions, such
as enzymatic reduction to a free radical species (Flitter &
Mason, 1988) and translocation of protein B23 (Yung et al.,
1990). Perhaps 'side effects' of this kind may play a crucial
role in the reaction of MGH-Ul to HESW and AMD treat-
ment. Therefore, as a hypothesis, we have to presume an
inherent characteristic of the cell line MGH-Ul to be respon-
sible for the observed effects in combination with HESW.
The mechanisms of action of both IFN-a and TNF-a, in
particular their cytostatic and cytotoxic effects, are not yet
fully understood (Baron et al., Fiers, 1991; Schutze et al.,
1992; Weil, 1992). Various intracellular reactions are trig-
gered after binding to specific transmembrane receptors.
Inhibition or induction of a range of proteins, enzymes and
oncogenes, as well as changes in the cytoskeleton, have been
described. It remains to be elucidated why some cell lines are
sensitive to certain cytokines while others are not. We
observed that growth-inhibitory effects on those cell lines
that were susceptible to a cytokine could be further enhanced
by HESW pretreatment. On the other hand, shock waves
could not make insensitive cell lines sensitive to either IFN-a
or TNF-a. The enhanced sensitivity to IFN-a diminishes less
rapidly than caused by CDDP and AMD. This is a first
indication that shock waves interfere with the pathways
underlying the cytotoxicity of cytokines than chemo-
therapeutic agents. Shock waves may induce an additional
disturbance of protein synthesis or enzymatic activity, thus
contributing to the cytolytic effect of cytokines. Nevertheless,
in recent research, there is some evidence that the plasma
membrane may also contribute to the cytotoxicity of both
IFN-x and TNF-a (Taylor-Papadimitriou & Rozengurt,
1985; Anghileri & Robert, 1987; Stalc et al., 1992). A shock
wave-induced change in this target may concur with the
theory that the action of cytokines is to bring about an
additional effect. In a model system ofexperimental tumours,
complete remission could be achieved by application of shock
waves after injection of TNF-x (Oosterhof et al., 1991). This
effect is ascribed to severe damage to tumour vascularisation
as a consequence of combined HESW and TNF-a action
(Steinbach et al., 1993). Though this is probably the decisive
factor, we could show that direct cytotoxic effects of
cytokines can also be augmented by HESW.
The data in Tables I-V suggest that there is a tendency for
DER values to decrease with increasing cytotoxicity. A pos-
sible explanation is the spatial distribution of the energy
density of the shock wave and its relation to cellular damage.
Cells exposed as a pellet have a relatively fixed position
within the focal region of the lithotripter. With respect to the
rapid decline in the energy density when moving away from
the acoustic axis of the propagating shock wave (see Figure
1) the whole cell population is not damaged to the same
extent by HESW exposure. Thus, an HESW-treated specimen
is expected to show a possibly higher but less homogeneous
sensitivity to subsequent drug exposure than cells without
pretreatment. This observation might indicate the need for a
multifocal exposure of tumours in in vivo systems in order to
achieve a uniform reaction of the tissue and to establish a
reproducible treatment protocol.
Previous studies and our results suggest that cell mem-
brane permeabilisation is the most prominent alteration
induced by essentially sublethal doses of HESW. Cells
recover from this type of damage rapidly. Thus, concurrent
treatment regimens with HESW and hydrophilic drugs look
promising since HESW can regionally render tissue more
susceptible to the drug with the prospect of reduced systemic
toxicity. Besides, there seem to be various intracellular
HESW-mediated alterations that interact with cytotoxic
drugs. Addition of several types of sublethal damage and
impaired repair mechanisms may explain the effects of such
combined treatments. Further studies are necessary to
achieve a profound understanding of how shock waves
interact with cells and cytostatic agents. Moreover, the
physical parameters of shock waves have to be taken into
consideration in order to optimise the protocol for a shock
wave-assisted chemotherapy.
This work was supported by Siemens Medizintechnik, Erlangen,
Germany.
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